Over a 9-yr period, heart transplantation was performed in 200 patients at
Sahlgrenska University Hospital. Of these 200 patients, 151 were followed f
or 1 to 9 yr with regard to renal function, hemodynamics, cyclosporin A con
centrations, and complications. Patients with a preoperative serum creatini
ne >130 mu mol/L received inotropic drugs to test for reversibility of rena
l dysfunction. The end point was graft failure. The average preoperative GF
R of 66 +/- 17 ml/min per 1.73 m(2) declined to 52 +/- 19, 44 +/- 16, and 3
7 +/- 17 at 1, 5, and 9 yr after heart transplantation, respectively. Altog
ether, the average GFR declined by 44%. There was no significant correlatio
n between the preoperative GFR and postoperative renal function or survival
. Recipient age was a predictor of renal function during the entire follow-
up. Severe renal dysfunction (GFR <20 ml/min per 1.73 m(2)) developed in 20
% of the patients, which was predicted by the recipient age at transplantat
ion together with the GFR 1 yr after transplantation. A nomogram that shows
the risk of developing severe renal dysfunction after heart transplantatio
n is presented. Cyclosporin A concentrations and treatment with statins, ca
lcium channel blockers, or angiotensin-converting enzyme inhibitors did not
correlate with the evolution of renal function. Patients with a preoperati
ve depressed renal function who improved on inotropic treatment seemed to h
ave a poorer outcome compared with the other study patients.